SARC

Our goal is to achieve breakthroughs in sarcoma research that help improve patient outcomes, and ultimately lead to a cure.

Find a SARC Study

View SARC clinical trials

Resources for Researchers

Biospecimens, Clinical Data

Who we are

Meet our experts

SARC FUNDING

LEARN HOW TO APPLY

Kirsch Mowery 2015

DAVID KIRSCH, MD, PHD
YVONNE MOWERY, MD, PHD
Duke University Medical Center
Mechanisms that Regulate Sarcoma Response to Immune Checkpoint Inhibition of PD1

Read more about Kirsch Mowery 2015
Log in to post comments

Man 2015

TSZ KWONG “CHRIS” MAN, PHD
Baylor College of Medicine
The Metastatic Role of Lysyl Oxidase in Osteosarcoma

Read more about Man 2015
Log in to post comments

Tseng 2015

WILLIAM W. TSENG, MD
University of Southern California
Immune Profiling in Well Differentiated/Dedifferentiated Liposarcoma

Read more about Tseng 2015
Log in to post comments

FDA Guidance for Clinical Trials during COVID-19

Recognizing the importance of cancer treatment and treatment on clinical trials in the presence of COVID-19, the FDA has issued guidance to help ensure that patients can continue their therapy. Oncology research centers are continuing to respond to COVID-19 precautions while keeping patient safety as the top priority.

MEET THE PEOPLE OF SARC

Kimberly Dooley, Research Project Manager

Kimberly Dooley joined SARC in September 2019 as Research Project Manager. Kimberly earned both her MPH and BS from the University of South Florida.

Read full bio

See all bios

SARC - Sarcoma Alliance for Research Through Collaboration, Ann Arbor

Kirsch Mowery 2015

Man 2015

Tseng 2015

Pages

Where can I find a sarcoma specialist?

Financial Contributions

FDA Guidance for Clinical Trials during COVID-19

MEET THE PEOPLE OF SARC